cystic Fibrosis
Cystic Fibrosis (CF) – Notes
Etiology
Most common fatal inherited disease in children
Autosomal recessive genetic disorder
Many possible mutations; most cause abnormal Na⁺/Cl⁻ transport across epithelial cells
Results in thick, sticky mucus in:
Airways → obstruction, infections
GI system → blocked pancreatic/liver ducts → ↓ protein & fat digestion → malnutrition
Deficiencies of fat-soluble vitamins (A, D, E, K)
Steatorrhea (fatty stools), diarrhea
Meconium ileus in newborns
Sweat glands: salty sweat
Anatomic Alterations
Bronchial gland hypertrophy & goblet cell metaplasia
Dehydrated airway surface → ↓ mucociliary clearance
Frequent infections (esp. Staph aureus, H. flu, Pseudomonas)
Airway obstruction → air trapping, atelectasis, bronchiectasis
Overdistention of alveoli
Restrictive & Obstructive Characteristics
Obstructive: mucus plugging, air trapping
Restrictive: from atelectasis, scarring, or advanced bronchiectasis
Screening & Diagnosis
Indications: “My baby tastes salty,” newborn screening
Pulmonary signs: chronic cough, sputum, recurrent infections
GI signs: failure to thrive, greasy/foul-smelling stools, vitamin deficiency
Other: meconium ileus (newborns), male infertility (adults)
Gold Standard: Sweat chloride test
Pilocarpine + electric current
Cl⁻ > 60 mEq/L = diagnostic
Clinical Appearance
May appear normal when stable
Exacerbation:
↓ compliance
Moderate–severe hypoxemia
↑ airway resistance
Accessory muscle use, pursed-lip breathing
Chest Exam & Imaging
Variable findings (depends on pneumonia, atelectasis, or air-trapping)
Diminished breath sounds
Bronchial sounds, crackles & wheezes
CXR: signs of atelectasis, pneumonia, bronchiectasis
Associated Pathology
Cor pulmonale → right heart failure (JVD, edema)
Polycythemia (from chronic hypoxemia)
Pneumothorax (spontaneous or with PPV)
PFTs & ABGs
PFTs: primarily obstructive, restrictive changes possible with severe disease
ABGs:
Early: respiratory alkalosis + hypoxemia
Chronic: ventilatory failure
Exacerbations: acute hypoventilation/hyperventilation on chronic failure
Treatment & Patient Education
Airway clearance (daily self-care is key):
CPT (chest physiotherapy)
HFCWO (Vest therapy)
PEP devices, autogenic drainage
Medications:
Bronchodilators (albuterol, ipratropium)
Dornase alfa (Pulmozyme) – mucus thinning
Hypertonic saline (possible)
TOBI (tobramycin inhalation) for Pseudomonas
Prevention:
Avoid infection exposure
Early recognition and aggressive treatment of infections